ImmunologybioRxiv
Interleukin-19 alleviates experimental autoimmune encephalomyelitis by attenuating antigen-presenting cell activation
H. Horiuchi, B. Parajuli, Y. Ogawa…·H. Takeuchi
This study shows IL-19 reduces experimental autoimmune encephalomyelitis by inhibiting macrophage activation and Th17 cell expansion, suggesting potential therapeutic use in multiple sclerosis.
DOI 10.3389/fimmu.2021.615898